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Skeletal muscle is responsible for the majority of glucose
disposal following meals, and this is achieved by insulin-
mediated trafficking of glucose transporter type 4 (GLUT4) to
the cell membrane. The eight-protein exocyst trafficking com-
plex facilitates targeted docking of membrane-bound vesicles, a
process underlying the regulated delivery of fuel transporters.
We previously demonstrated the role of exocyst subunit EXOC5
in insulin-stimulated GLUT4 exocytosis and glucose uptake in
cultured rat skeletal myoblasts. However, the in vivo role of
EXOC5 in skeletal muscle remains unclear. Using mice with
inducible, skeletal-muscle-specific knockout of exocyst subunit
EXOC5 (Exoc5-SMKO), we examined how muscle-specific
disruption of the exocyst would affect glucose homeostasis
in vivo. We found that both male and female Exoc5-SMKOmice
displayed elevated fasting glucose levels. Additionally, male
Exoc5-SMKO mice had impaired glucose tolerance and lower
serum insulin levels. Using indirect calorimetry, we observed
that male Exoc5-SMKO mice have a reduced respiratory ex-
change ratio during the light period and lower energy expendi-
ture. Using the hyperinsulinemic–euglycemic clampmethod, we
further showed that insulin-stimulated skeletal muscle glucose
uptake is reduced in Exoc5-SMKO males compared with wild-
type controls. Overall, our findings indicate that EXOC5 and
the exocyst are necessary for insulin-stimulated glucose uptake
in skeletal muscle and regulate glucose homeostasis in vivo.
Skeletal muscle is responsible for 80 to 90% of insulin-
stimulated glucose uptake in the body (1). Insulin triggers the
targeted trafficking of GLUT4 to the cell membrane, enabling
glucose uptake into cells, and insulin-resistant cells showdefects
in GLUT4 trafficking to the membrane (2). The “solute carrier
2A” (SLC2A or GLUT) family of glucose transporters allow
glucose to cross the cell membrane by facilitated diffusion.
GLUT1 is constitutively present on the plasma membrane of
cells in most tissues, while GLUT4 is the principal insulin
responsive glucose transporter (3). In basal state, GLUT4 is
sequestered inGLUT4 storage vesicles (GSVs) in the cytosol (4).
When stimulated by insulin, GSVs are translocated along the
cytoskeleton toward the cell membrane (5), where they are
“docked” to the plasma membrane by tethering protein com-
plexes (6). It is only after docking, when the membrane of the
GSVs can be fused to the plasma membrane with the assistance
of SNAP Receptor (SNARE) proteins (7).
In 3T3-L1 cells, it has been demonstrated that the exocyst
protein complex is essential for the delivery of GLUT4-
containing vesicles to the plasma membrane in response to
insulin (8). The exocyst complex is an eight-member hol-
ocomplex that ensures that certain exocytic vesicles are traf-
ficked to the appropriate location on the plasma membrane
(9). The exocyst complex member EXOC6 is necessary for
GLUT4 exocytosis in adipocytes (10), and the overexpression
of EXOC3 and EXOC4 increases the magnitude of insulin-
stimulated glucose uptake in cultured adipocytes (11).
The vast majority of the previous research demonstrating
the essentiality of the exocyst complex for insulin-stimulated
GLUT4 exocytosis has been performed in vitro in cultured
adipocytes (12, 13). We have recently demonstrated that the
exocyst complex is necessary for GLUT4 exocytosis in
cultured skeletal myoblasts and myotubes as well (14). In
healthy individuals, skeletal muscle takes up 80 to 90% of
glucose in response to insulin, and one of the earliest detect-
able signs of insulin resistance preceding type 2 diabetes (T2D)
is reduced insulin-stimulated glucose uptake in skeletal muscle
(1). In the skeletal muscle cells of people with T2D, the insulin
signaling pathway and subsequent GLUT4 exocytosis are
suppressed (15), impairing glucose uptake into cells. A detailed
map of the processes between the activation of the insulin
receptor and the exocytosis of GLUT4 in skeletal muscle is yet
to be completed. The discovery of new effectors of the insulin
signaling pathway could provide novel therapeutic approaches
for the treatment of insulin resistance and T2D (16). In this
article, we are the first to report that in vivo disruption of the
exocyst complex affects skeletal muscle glucose uptake and
homeostasis in a novel conditional knockout mouse model.
Results
Generation of skeletal-muscle-specific Exoc5 knockout mice
Previously, we demonstrated that the exocyst subunit
EXOC5 is essential for insulin-stimulated GLUT4 exocytosis* For correspondence: Noemi Polgar, polgar@hawaii.edu.
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and glucose uptake in cultured rat skeletal myoblasts (17).
To study the consequences of in vivo disruption of Exoc5 and
the exocyst, we generated skeletal-muscle-specific Exoc5
conditional knockout (Exoc5-SMKO) mice. We crossed our
“floxed” Exoc5 mouse strain with the human skeletal muscle
actin Mer-Cre-Mer (HSA-MCM) mice strain and treated
them with tamoxifen to induce Cre recombinase activation
and thus inactivate Exoc5 in a skeletal-muscle-specific
manner (Fig. 1A).
We utilized a tdTomato reporter mouse strain to confirm
skeletal-muscle-specific Cre activity. As anticipated,
tamoxifen-treated Exoc5fl/+;HSA-MCM/+;To/+ female mice
expressed tdTomato almost exclusively in skeletal muscle
tissues (Fig. 1A, top panel). A few cardiomyocytes also
expressed tdTomato (Fig. 1A, middle panel), but no tdTomato
expression was detected in the liver (Fig. 1A, lower panel),
lung, or kidney tissues (data not shown). We designed a PCR-
based assay to test genomic DNA recombination, where a
product is obtained only when exons 7 to 10 are removed from
the Exoc5 gene. Recombination of genomic DNA was detected
in male Exoc5-SMKO mice in skeletal muscle and bladder
samples, but not in other tissues assayed (Fig. 1B).
Quantitative real-time PCR revealed that the knockout
muscle tissue has significantly less Exoc5 mRNA expressed
than controls (Fig. 1C) in both sexes. Western blot analysis
demonstrated that Exoc5-SMKO male and female mice have
decreased EXOC5 protein levels in soleus muscle tissue
compared with littermate controls (Fig. 1D). Thus, in Exoc5-
SMKO mice, following tamoxifen treatment, the Cre-
recombinase was expressed in a skeletal-muscle-specific
manner, and EXOC5 expression was markedly diminished in
skeletal muscle tissue at both the RNA and protein levels, with
similar efficiency in both male and female mice. Lastly,
skeletal-muscle-specific ablation of Exoc5 did not impair
neuromuscular muscle function in either sex, as Exoc5-SMKO
performed similarly to control mice in open field and rotarod
testing (Fig. S1).
Altered energy expenditure and respiratory exchange ratio in
Exoc5-SMKO mice
An indirect calorimetry study was conducted to assess
whole-body energy balance in Exoc5-SMKO mice. The energy
expenditure (EE) rate over a 24-h period was significantly
reduced during both light and dark cycles in male Exoc5-
SMKO mice, but not in female mice (Fig. 2, A–D). Addition-
ally, respiratory exchange ratio (RER), measured over the
course of a 24-h period, was significantly lower in male Exoc5-
SMKO mice during light cycle and in female Exoc5-SMKO
mice during both the light and dark cycle suggesting decreased
glucose utilization in these mice compared with controls
(Fig. 2, E–H). There were no significant differences in body
weight, activity level (Fig. S2, A–C), and food or water intake
(data not shown) between Exoc5-SMKO and control mice.
These observations suggest that skeletal-muscle-specific
disruption of Exoc5 affects whole-body energy substrate
utilization.
Altered glucose homeostasis in Exoc5-SMKO mice
In order to analyze the effect of the Exoc5 knockout in
skeletal muscle on glucose homeostasis, we first measured
fasting glucose and insulin levels. Blood glucose levels
following overnight fast in male and female Exoc5-SMKO mice
were significantly higher than in littermate controls (Fig. 3A),
suggesting impaired glucose homeostasis and hepatic insulin
resistance.
We also measured serum insulin levels by ELISA following a
6-h fast and found that male Exoc5-SMKO mice had signifi-
cantly lower insulin levels than controls (Fig. 3B). This effect
was selective to male mice because female Exoc5-SMKO mice
had similar insulin levels to their littermate controls. The ex-
amination of pancreatic islets found no significant differences
in islet size compared with controls in either sex (Fig. 3C).
During glucose tolerance test, blood glucose was measured
every 30 min for 2 h following a glucose bolus. Male Exoc5-
SMKO mice showed a slower clearance of glucose during GTT
compared with male control mice, and area under the curve of
GTT was significantly increased in male Exoc5-SMKO mice
compared with controls (Fig. 3, D and F), suggesting impaired
glucose tolerance in male Exoc5-SMKO mice. However,
glucose tolerance and area under the curve of GTT were not
significantly different in female Exoc5-SMKO mice compared
with controls (Fig. 3, E and F).
We performed insulin tolerance test (ITT) in Exoc5-SMKO
mice. The mice were fasted for 6 h and given an IP injection of
insulin. Blood glucose was measured every 30 min for 2 h.
Glucose clearance during ITT was similar between male and
female Exoc5-SMKO mice and controls (Fig. 3, G and H). Area
under the curve calculations depict a similar response to in-
sulin in both male and female Exoc5-SMKO compared with
controls (Fig. 3I). We also assessed insulin signaling pathway
activation in Exoc5-SMKO mice compared with controls and
found that the insulin signaling pathway component Akt1 is
phosphorylated in both Exoc5-SMKO and control mice
following insulin injection (Fig. 3J). Taken together, skeletal
muscle knockout of Exoc5 resulted in increased fasting gly-
cemia and impaired glucose tolerance, but did not impair a
functional insulin signaling pathway activation. Of note,
gender-specific differences in glucose tolerance were observed
in these mice.
Male Exoc5-SMKO mice develop insulin resistance in skeletal
muscle
Body composition analysis showed that Exoc5-SMKO and
control male mice had no detectable differences in whole-body
fat mass and lean mass (Fig. 4, A and B). We performed
hyperinsulinemic–euglycemic clamp in awake mice to mea-
sure whole-body insulin sensitivity and glucose metabolism in
individual organs. Whole-body glucose turnover during
clamps tended to decrease by 10% in male Exoc5-SMKO mice
compared with male controls, similarly to whole-body
glycogen synthesis, although the differences did not reach
statistical significance (p = 0.0851 and p = 0.0587, respectively)
(Fig. 4, C and D). Whole-body glycolysis was not significantly
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different in male Exoc5-SMKO mice compared with male
controls (Fig. 4E). Basal and clamp hepatic glucose production
and hepatic insulin action were not altered in male Exoc5-
SMKO mice (Fig. 4F).
Insulin-stimulated glucose uptake in individual organs was
measured using a bolus injection of labeled 2-deoxyglucose
during clamps. Skeletal muscle glucose uptake in response to
insulin was significantly decreased in Exoc5-SMKO mice
compared with controls (Fig. 4G). The insulin-stimulated
glucose uptake in adipose tissue was not altered in Exoc5-
SMKO mice (Fig. 4H). The impaired skeletal-muscle-specific
glucose uptake was not due to defective insulin signaling or
total GLUT4 expression because no differences were detected
in the mRNA abundance of GLUT4, insulin receptor (InsR),
insulin receptor substrate 1 (IRS-1), protein-dependent kinase
1(Pdk1), Rho-related GTP-binding protein (RhoQ), and RAC-
beta serine threonine-protein kinase (Akt2) (Fig. 3J, Fig. S3). In
support of decreased skeletal-muscle-specific glucose uptake,
immunofluorescent staining of skeletal muscle tissues of
insulin-injected animals revealed a disrupted GLUT4 mem-
brane integration with membrane-proximal accumulation of
GLUT4 vesicles in Exoc5-SMKO male and female mice
compared with littermate controls (Fig. 4I) These results
indicate that impaired glucose tolerance and insulin resistance
in male Exoc5-SMKO mice were mostly due to decreases in
insulin-stimulated glucose uptake in skeletal muscle. Based on
these results, and our metabolic cage data demonstrating
decreased glucose utilization, we expected a switch toward
increased fatty acid metabolism in skeletal muscle tissues of
our Exoc5-SMKO mice. Therefore, we quantified expression of
proteins responsible for fatty acid flux as well as mitochondrial
content in soleus muscles. Of note, we were not able to detect
differences in fatty acid transporter/CD36, lipoprotein lipase
(LPL), or mitochondrial components translocase of the outer
mitochondrial membrane 20 (TOMM20), voltage-dependent
anion-selective channel protein (VDAC1), and cytochrome c
oxidase complex four (CoxIV) between groups (Fig. S4).
With reduced muscle glucose uptake but no differences in
adiposity, we hypothesized a rerouting of increased glucose to
the liver. Thus, we evaluated liver morphology and lipid con-
tent using Oil Red O staining. We have detected a significantly




Figure 1. Conditional knockouts of Exoc5 in mouse skeletal muscle were generated. A, fluorescent microscopy evaluating tissue-specific Cre expression
using a mouse line with a tdTomato (To) reporter allele. The tissue sections are from female mice. B, recombination PCRs from genomic DNA of various
tissues of tamoxifen-treated male mice to detect deletion of exons 7 to 10. C, real-time quantitative PCR measuring skeletal-muscle-specific EXOC5 mRNA
expression (normalized to RPLP0) in Exoc5-SMKO and CTRL mice. D, representative image of a Western blot analysis (upper panel) used for the quantification
(lower panel) of EXOC5 protein levels (normalized to Vinculin) in the soleus of Exoc5-SMKO and CTRL mice. Error bars = standard deviation, *p ≤ 0.05,
**p ≤ 0.01.
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and females compared with littermate controls (Fig. 5A). A
significantly higher hepatic triglyceride content was indeed
measured in the homogenate of Exoc5-SMKO male mice
(Fig. S5A). We quantified the protein levels of CD36, LPL in
the livers of Exoc5-SMKO and control mice to decipher if lipid
accumulation was due to increased uptake (Fig. 4B, and
Fig. S5B), but found no significant differences between groups.
In support of these findings, we detected no differences in
liver-specific uptake of the fluorescent lipid analog, BODIPY-
palmitate in male or females Exoc5-SMKO mice compared
with controls (Fig. S5C). To investigate if hepatic lipid accu-
mulation was due to de novo lipogenesis, we measured protein
levels of Fatty Acid Synthase (FASN), as well as mRNA levels
of ChREBP, SREBP1, and Acetyl CoA Carboxylase 1
(ACACA), but detected no significant differences (Fig. S5, D–
G). Moreover, there were no differences in serum triglycerides
and markers of liver function Aspartate Aminotransferase
(AST) and Alanine Aminotransferase (ALT) activity levels
(Fig. S5, H–J).
Chronic high-fat feeding exacerbates insulin resistance in
male Exoc5-SMKO mice
Male and female Exoc5-SMKO and control mice were
challenged with a high-fat diet (HFD) for 16 weeks to assess if
impaired exocyst function affects diet-induced changes in






Figure 2. Indirect calorimetric analysis indicates a shift from glucose utilization in skeletal muscle specific Exoc5 knockout mice during daylight
hours and a lower energy expenditure. Indirect calorimetry was performed on Exoc5-SMKO and CTRL mice by placing them in metabolic cages. Energy
expenditure (EE) for male (A) and female (B) mice was calculated over a 24-h period, the dark cycle is symbolized by the grayed-out area. Area under the
curve was calculated for the light period (C) and the dark period separately (D). The respiratory exchange ratio (RER) for male (E) and female (F) mice was
calculated based on the ratio of O2 flowing into the cage and the CO2 flowing out of the cage over a 24-h period, the dark cycle is symbolized by the grayed-
out area. Area under the curve was calculated for the light period (G) and the dark period separately (H). Error bars = standard deviation. *p ≤ 0.05,
**p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001.
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after 16 weeks of HFD, we did not detect significant differences
in body weights between knockout and control animals
(Fig. 6A). GTT revealed significantly reduced glucose tolerance
in HFD-fed male Exoc5-SMKO mice compared with controls,
whereas no difference in glucose tolerance could be detected
in HFD-fed Exoc5-SMKO females compared with the litter-
mate controls (Fig. 6, B–D).
ITT of the HFD-fed cohorts also showed reduced glucose
clearance in male Exoc5-SMKO mice compared with con-
trols, but no differences between female Exoc5-SMKO mice
and controls after HFD (Fig. 6, E–G). While fasting serum
insulin levels increased compared with regular diet-fed
cohort, there were no significant differences in fasting






Figure 3. Glucose homeostasis is perturbed in Exoc5 skeletal muscle knockout animals. A, Exoc5-SMKO and CTRL animals were fasted overnight, and
fasting blood glucose concentrations were measured via tail bleed. B, six-hour fasting insulin levels were measured in Exoc5-SMKO and control littermate
animals using serum samples and an ELISA assay. C, representative images of pancreatic islet immunofluorescent staining (left panel) and quantification of
islet size in Exoc5-SMKO and CTRL mice (right panel). White scale bars, 20 μm. D and E, for the glucose tolerance testing, blood glucose concentrations were
measured at 30-min intervals following an intraperitoneal bolus of glucose (1 mg/kg). F, quantification of area under the curve for data shown in D and E. G
and H, prior to insulin tolerance testing, 4- to 5-month-old Exoc5-SMKO and CTRL mice were fasted for 6 h and blood glucose levels were measured by tail
bleed. Following fasting glucose measurement, an intraperitoneal injection of insulin was administered (1 U/kg). Blood glucose was measured at baseline
and every 30 min for 2 h by tail blood sampling. I, area under the curve calculations for data presented in G and H. J, Western blots (left panel) and
quantification (right panel) of insulin signaling pathway component Akt in Exoc5-SMKO and CTRL following insulin injection. Error bars = standard deviation,
*p ≤ 0.05; **p ≤ 0.01.
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Exoc5-SMKO mice and littermate controls (Fig. S6, A and B).
There were no differences in fasting serum triglyceride levels
either (Fig. S6C). Of note, when we evaluated hepatic lipid
accumulation in the HFD-fed animals, we could not detect a
significant difference between Exoc5-SMKO and control
animals in either sex (Fig. 6H). In addition, we did not detect
significant differences in CD36 (Fig. 6I), LPL, and FASN
(Fig. S6, D and E) protein levels in the livers of Exoc5-SMKO
mice either.
Discussion
Insulin-stimulated glucose uptake by skeletal muscle is an
essential part of glucose homeostasis (18). Insulin stimulation
in a healthy individual results in the exocytosis of the GLUT4
and subsequent glucose uptake into major metabolic tissues
such as skeletal muscle, fat, and heart (19). Discordance in the
mechanisms that coordinate the GLUT4 exocytosis in skeletal
muscle may contribute to the primary dysfunction in T2D
(20).
Previous studies using gene knockout animals have
demonstrated that GLUT4 and its function are essential for
maintaining glucose homeostasis. The heterozygous whole-
body knockout of GLUT4 in mice resulted in decreased
glucose uptake in fat and muscle cells, increased adipocyte
size, hypertension, and cardiac hypertrophy, as well as hepatic
steatosis (21). Furthermore, knockout of GLUT4 in skeletal
muscle alone resulted in reduced glucose tolerance, and the
decreased serum lactate and β-hydroxybutyrate levels in
skeletal muscle GLUT4-null mice indicated decreased glucose
oxidation (22). However, GLUT4 overexpression in adipose
tissue was able to rescue insulin resistance in mice lacking
GLUT4 in skeletal muscle (23).
Figure 4. Exoc5-SMKO male mice have reduced skeletal muscle glucose uptake and whole-body glucose turnover during hyperinsulinemic–
euglycemic clamp. A and B, proton magnetic resonance spectroscopy was applied to quantify whole-body lean and fat mass in male Exoc5-SMKO and
control animals. C–F, hyperinsulinemic–euglycemic clamp was performed in awake mice to assess whole-body glucose turnover (C), whole-body glycogen
synthesis (D), whole-body glycolysis (E), hepatic insulin action (insulin-mediated percent suppression of basal hepatic glucose production) (F), in Exoc5-
SMKO and control males. G and H, insulin-stimulated glucose uptake in skeletal muscle (gastrocnemius) (G) and white adipose tissue (epididymal) (H)
was determined following a bolus injection of 2-[14C] deoxy-glucose during clamp). I, immunofluorescent staining of skeletal muscle tissues of insulin-
injected animals. GLUT4 vesicles are in red and dystrophin is labeled in green in Exoc5-SMKO male and female littermate controls. White scale bars,
5 μm. Error bars = standard deviation, *p ≤ 0.05.
Exocyst-regulated skeletal muscle glucose uptake in mice
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The eight-protein exocyst complex is involved in vesicle
docking and has been evolutionarily conserved from yeast to
humans (24). It has been extensively demonstrated that the
exocyst complex is essential for insulin-stimulated GLUT4
exocytosis in cultured adipocytes (11, 12, 25). The siRNA
knockdown of EXOC6/6b inhibited GLUT4 exocytosis in 3T3-
L1 adipocytes (10). On the other hand, overexpression of
EXOC3 and EXOC4 in 3T3-L1 adipocytes increased the
magnitude of glucose transport in response to insulin (11).
There have been very few studies directly examining the role of
the exocyst complex in skeletal muscle tissues. We have pre-
viously demonstrated that chemical inhibition of the exocyst
complex and the heterozygous knockout of Exoc5 lead to a
reduction in insulin-stimulated GLUT4 membrane delivery
and glucose uptake in rat skeletal myoblasts (17).
Here, we are the first to create an in vivomodel of a skeletal-
muscle-specific knockout of a component of the exocyst
complex. Exoc5-SMKO mice appeared to have normal
neuromuscular function as well as an intact insulin signaling
pathway activation, and no differences in the expression levels
of genes that are involved in insulin-stimulated glucose uptake
were detected.
Food and water intake, activity level, body weight, and body
composition were similar between Exoc5-SMKO and control
animals as measured using metabolic cages and proton
magnetic resonance spectroscopy. Our indirect calorimetry
data suggest that the skeletal muscle depletion of EXOC5 re-
sults in a metabolic shift from glucose utilization toward
increased amino acid and fatty acid metabolism in both sexes.
A reduced carbohydrate utilization as an energy substrate is
likely due to an impaired glucose uptake in skeletal muscle. In
support of our findings, insulin-resistant mice were previously
shown to have RER of approximately 0.8 and an overnight
fasting glucose of 600 mg/dl starting at 15 weeks of age, while
wild-type mice had an RER of 0.9 and a fasting glucose level
around 100 mg/dl (26).
Hyperinsulinemic–euglycemic clamp demonstrated that
insulin sensitivity was reduced selectively in skeletal muscle of
male Exoc5-SMKO mice. Glucose uptake in adipose tissue was
similar between Exoc5-SMKO mice and controls. No differ-
ences in whole-body glycogen synthesis were detected in
Exoc5-SMKO mice. Although, 70 to 90% of glucose absorbed
by skeletal muscle is converted into glycogen during a
hyperinsulinemic–euglycemic clamp (27) and skeletal muscle
stores 80% of the of the body’s glycogen (27), the effect of the
impaired skeletal muscle glucose uptake was insufficient to
alter these parameters. Overnight fasting glucose is higher in
Exoc5-SMKO mice, and our findings indicate that the excess
glucose may be routed to the liver, as suggested by hepatic
lipid accumulation. Yet, we were not able to detect any
A
B
Figure 5. Exoc5-SMKO mice had increased hepatic lipid accumulation, yet no difference in insulin-sensitive fatty acid transporter CD36 protein
levels was detected. A, representative images of control and Exoc5-SMKO liver samples stained with Oil Red O (left panels). Quantification of the ratio of Oil
Red O-stained areas in liver tissues (right panel). B, images of Western blot analysis (left panel) and quantification (right panel) of CD36. CD36 levels in B as
well as LPL and FASN levels in Fig. S5 were sequentially analyzed on a single Western blot, and their respective signal intensities were normalized using the
same βactin loading control measurements. Thus we show the same βactin loading control images in Fig. S5, B and D as well. Black scale bars, 100 μm,
Error bars = standard deviation, **p ≤ 0.01.
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significant differences in hepatic lipid uptake or de novo
lipogenesis and further investigation is warranted. The
hyperinsulinemic–euglycemic clamp data also showed no ef-
fects on hepatic insulin sensitivity as insulin maximally sup-
pressed hepatic glucose production in Exoc5-SMKO and
control mice. It should be noted, however, that since hepatic
glucose production was maximally suppressed by insulin
during clamp, potential effects on hepatic insulin action may
have been masked in this study.
While body weights and body composition of Exoc5-SMKO
and littermate control mice were similar for both sexes,
glucose tolerance was significantly reduced in male Exoc5-
SMKO mice only. The glucose tolerance of female Exoc5-







Figure 6. High-fat diet challenge of skeletal-muscle-specific Exoc5-SMKO animals confirms disrupted glucose homeostasis. A, weekly body weight
measurements of Exoc5-SMKO and control animals during a 16-week high-fat diet challenge. B and C, during the glucose tolerance testing, blood glucose
concentrations were measured at 30-min intervals following an intraperitoneal bolus of glucose (1 mg/kg). D, quantification of area under the curve for data
shown in B and C. E and F, during insulin tolerance testing, blood glucose was measured every 30 min for 2 h blood glucose measurement following an
intraperitoneal injection of insulin (1 U/kg). G, area under the curve calculations for data presented in E and F. H, representative images of control and Exoc5-
SMKO liver samples stained with Oil Red O (left panel) and quantification of the ratio of Oil Red O-stained areas in liver tissues (right panel) in Exoc5-SMKO
and littermate control animals following. Black scale bars, 100 μm. Images of Western blot analysis (upper panel) used for the quantification of I, images of
Western blot analysis (left panel) used for the quantification of CD36 protein levels (normalized to β-actin) in the livers of Exoc5-SMKO and control mice
(right panel). Error bars = standard deviation, *p ≤ 0.05; **p ≤ 0.01, ****p ≤ 0.0001.
Exocyst-regulated skeletal muscle glucose uptake in mice
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responsive tissues between male and female mice may protect
female mice from dysregulation of glucose homeostasis.
Studies on mice have shown that there are more than 300
differentially expressed genes in skeletal muscle between males
and females (28). Thus, the gender-specific effects we describe
in the glucose homeostasis of our Exoc5-SMKO animals
warrant further investigation.
No differences in insulin tolerance were observed between
Exoc5-SMKO and control mice. It has been documented that
insulin tolerance test may lack the sensitivity necessary to
resolve metabolic differences in mice, in particular when
glucose metabolism is altered in selective metabolic organs
(29). Male Exoc5-SMKO had lower insulin levels yet we did
not find any significant differences in pancreatic islet size or
insulin-positive cell ratios compared with controls.
The ad libitum HFD treatment closely mimics the effect of
the nutrient-dense Western diet in humans. After 16 to
20 weeks, mice gain 20 to 30% more weight than mice fed
normal chow and hyperglycemia usually begins after 4 weeks
(30). After a 16-week HFD, the body weights of Exoc5-SMKO
and littermate controls were similar. Male Exoc5-SMKO mice
challenged with a HFD for 16 weeks had decreased glucose
tolerance and reduced glucose clearance in response to
exogenous insulin, and female Exoc5-SMKO mice were similar
to controls. This may be due to estrogen’s role in female mice
contributing to an increased reliance on lipid oxidation (31),
masking any possible effects of altered skeletal muscle glucose
uptake. The differences in male and female muscle and adipose
tissue anatomy and physiology were mentioned earlier.
Lipid dysregulation, especially elevated serum triglycerides
are commonly associated with T2D (32). Elevated serum tri-
glycerides can be a potential sign of liver dysfunction (32).
However, fasting serum insulin and serum triglycerides were
not significantly different between Exoc5-SMKO and control
mice challenged with a HFD. Of note, no significant impair-
ment of liver function could be detected in our Exoc5-SMKO
mice compared with controls.
Our previous study demonstrated that reducing the amount
of EXOC5 impairs the ability of mouse skeletal muscle cells to
uptake glucose in response to insulin (17). This was due to a
failure to increase the amount of GLUT4 transporters at the
plasma membrane. In this study, we highlight the central role
of the exocyst complex in insulin-stimulated glucose uptake in
skeletal muscle in vivo. We demonstrate that skeletal-muscle-
specific knockout of Exoc5 causes insulin resistance in mice,
and impaired skeletal-muscle-specific glucose uptake triggers a
shift from carbohydrate metabolism toward lipid utilization
and increases hepatic lipid accumulation as a possible sub-
strate redistribution from skeletal muscle tissues to the liver.
Ongoing work will further investigate the molecular mecha-
nism of exocyst-mediated GLUT4 trafficking in skeletal muscle.
Experimental procedures
Animals
The “floxed” Exoc5 (Exoc5fl/fl) mouse strain (kindly pro-
vided by Dr Ben Fogelgren, University of Hawaii) was
generated and validated as previously described (33). To
inactivate Exoc5 in a muscle-specific manner, we obtained
HSA-MCM mice (Tg(ACTA1-cre/Esr1*)2Kesr/J) from Dr
Karyn Esser from the University of Kentucky Center for
Muscle Biology. This HSA-MCM strain has a tamoxifen-
inducible form of Cre recombinase (CreERT2) under the
control of the human skeletal actin (HSA) promoter (34). The
B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato) Hze/J reporter
mouse strain was used to detect Cre recombinase activity
through Cre-activated expression of the tdTomato red fluo-
rescent protein (kindly provided by Dr Michelle Tallquist,
University of Hawaii) (35).
All animal procedures and protocols were carried out in
accordance with IACUC specifications approved by the Uni-
versity of Hawaii Animal and Veterinary Services and the
University of Massachusetts Medical School.
Tamoxifen treatment
Mice at 6 to 8 weeks of age were given tamoxifen-containing
chow (Envigo cat #TD. 130860) ad libitum for 2 weeks to
induce skeletal-muscle-specific Cre recombinase activation
and subsequent gene recombination. To assess tissue-specific
Cre recombinase activation, heterozygous Exoc5fl/+; HSA-
MCM/+;tdTomato/+ mice, age- and sex-matched littermate
control animals of Exoc5fl/fl; +/+,tdTomato/+ genotype (both
carrying the tdTomato reporter allele) were subjected to
tamoxifen treatment. The Cre activation was assessed based on
expression of the red fluorescent tdTomato in various tissues.
To evaluate glucose homeostasis, Exoc5fl/fl;HSA-MCM/+
(Exoc5-SMKO) mice and age- and sex-matched littermate
animals of Exoc5fl/fl; +/+ (control) genotype were used in all
experiments.
High-fat diet and body composition analysis
Ten- to twelve-week-old Exoc5-SMKO and control mice
were given a HFD (Envigo cat #TD.07011; containing 29% Fat,
30% Carbohydrate, 26% protein by weight) for 16 weeks. Body
weight was measured every 7 days. Whole-body fat and lean
mass of male 20-week-old male Exoc5-SMKO and control
mice were noninvasively assessed using Proton magnetic
resonance spectroscopy (1H-MRS, EchoMRI, EchoMedical
Systems) (36).
Motor function testing
With assistance from the JABSOM Murine Behavior and
Metabolic Research Support Facility (http://mbmc.jabsom.
hawaii.edu), open-field and Rotarod tests were performed to
assess locomotion and motor coordination as previously
described (37).
Glucose and insulin tolerance test
For intraperitoneal glucose tolerance test (GTT), overnight
fasted mice were injected intraperitoneally (IP) with glucose
(1 mg/kg), and blood glucose levels were measured using a
OneTouch Ultra handheld glucometer. For insulin tolerance
test, mice were fated for 6 h, insulin was subsequently
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delivered via intraperitoneal (IP) injection at 0.75 IU/kg, and
glycemia was measured using a OneTouch Ultra handheld
glucometer.
Measurement of energy balance and indirect calorimetry
With assistance from the University of Hawaii Murine
Behavior and Metabolic Research Support Facility (http://
mbmc.jabsom.hawaii.edu), whole-body energy balance was
assessed via indirect calorimetry using the Panlab OxyletPro
System (Harvard Apparatus, Barcelona, Spain). Adult (16-
week-old) male Exoc5-SMKO and control animals were
weighed and individually housed in metabolic cages. Following
a 24-h acclimation period, food and water intake, physical
activity, and energy expenditure (O2 consumption, CO2 pro-
duction) were measured over a 24-h period. Data collection
and calculations were performed using the Panlab META-
BOLISM software.
Hyperinsulinemic–euglycemic clamp to assess insulin
sensitivity in vivo
Hyperinsulinemic–euglycemic clamps were conducted in
male 20-week-old Exoc5-SMKO and control mice as previ-
ously described (38). At the end of the clamps, mice were
anesthetized, and tissues were taken for biochemical analysis.
Glucose concentrations during clamps were analyzed using
10 μl plasma by a glucose oxidase method on Analox GM9
Analyser (Analox Instruments Ltd). Plasma concentrations of
[3-3H]glucose, 2-[14C]DG, and 3H2O were determined
following deproteinization of plasma samples as previously
described (29). For the determination of tissue 2-[14C]DG-6-
Phosphate content, tissue samples were homogenized, and
the supernatants were subjected to an ion-exchange column to
separate 2-[14C]DG-6-P from 2-[14C]DG.
Rates of basal hepatic glucose production (HGP) and
insulin-stimulated whole-body glucose turnover were deter-
mined as previously described (38).
Serum and hepatic triglyceride, serum insulin, and HbA1c
analysis
Male and female Exoc5-SMKO and control mice were fasted
for 6 h and upon euthanasia, blood was drawn by cardiac
puncture. Plasmawas separated using BDMicrotainer Capillary
Blood Collector and BD Microgard Closure tubes and stored
at −20 C. Serum triglyceride wasmeasured using a Triglyceride
Colorimetric Assay Kit (Cayman Chemical Catalog # 10010303)
per themanufacturer’s recommendation with a SpectraMaxM3
microplate reader (Molecular Devices, LLC). Serum insulin was
measured using a Mouse Ultra Sensitive Insulin ELISA kit
(ALPCO catalog #80-INSMSU-E01).
Histology and Immunofluorescence
All samples were imaged using an Olympus BX41 micro-
scope. Image processing, quantification of pancreatic islet
areas, and oil red staining were performed using ImageJ (39).
For immunofluorescence, deparaffinized and rehydrated
sections were subjected to a citrate-based antigen retrieval.
After permeabilization and blocking, sections were incubated
with primary antibodies (anti-insulin (Cat #66198-1-Ig, Pro-
teintech Group, Inc); anti-glucagon (Cat # 15954-1-
AP,Proteintech Group, Inc)) overnight at 4 C and incubated
with appropriate fluorescent secondary antibodies (DyLight
488 Anti-Rabbit IgG and DyLight 594 Anti-Mouse, Vector
Laboratories) for detection. Cell nuclei were stained with
DAPI.
In the sections stained for insulin and glucagon, the borders
of each pancreatic islet were identified morphologically and
marked using the pen tool in ImageJ. The area of each islet was
calculated with ImageJ software using the set scale function
corresponding to the 20x scale bar. Insulin-positive nuclei
were counted based on fluorescent signal. All islets with an
area >566 μm
ˇ
2 (corresponding to a diameter of >27 μm),
approximately corresponding to islets containing a minimum
of eight nuclei, were regarded for analysis.
Western blot analysis
Skeletal muscle proteins were extracted using an extraction
buffer (20 mM Tris, 137 mM NaCl, 2.7 mM KCl, 1 mM
MgCl2, 1% Triton X-100, 10% glycerol, 1 mM EDTA, 1 mM
DTT) and a mechanical homogenizer. Lysates were separated
on a gradient (4–15%) SDS-PAGE gel, and proteins were
transferred onto a polyvinylidene fluoride membrane. The
membrane was incubated with primary antibodies (AKT1,
Santa Cruz, sc-5298; EXOC5, Proteintech, 17593-1-AP;
GAPDH, Proteintech, 60004-1-Ig; FASN, Proteintech, 10624-
2-AP; CD36, Novus, NB400-144; LPL, Novus, AF7197; pAKT
(Ser 473), Cell Signaling, 4060T; TOMM20, Abcam, ab186735;
VDAC1, Abcam, ab129002; Vinculin, Abcam, ab129002;
CoxIV, Cell Signaling, 4850) diluted 1:1000 in 5% BSA in PBST
at 4 C overnight, and with fluorescent secondary antibodies
(IRDye 800 conjugated goat anti-rabbit IgG, LI-COR Bio-
sciences, 926-32211; IRDye 680RD donkey anti-mouse IgG,
LI-COR Biosciences, 926-68072) diluted 1:15,000 in 5% BSA in
PBST with 0.02% SDS. Blots were scanned with a LI-COR
Odyssey Clx scanner, and densitometry was performed using
the Image Studio software (LI-COR Biosciences).
Quantitative real-time PCR analysis
Total RNA from the quadriceps femoris muscle was collected
using the RNeasy Fibrous Tissue Mini Kit (Qiagen Germany).
The iScript reverse transcriptase (Bio-Rad) was used to generate
cDNA from extracted RNA samples. Quantitative PCR was
performed on a CFX96 Real Time System (Bio-Rad), using the
iTaq Universal SYBR Green Supermix (Bio-Rad) using prede-
signed primer assays (PrimeTime, Integrated DNA Technolo-
gies). Gene expression was normalized to Rplp0. Quantitative
PCR primer sequences are listed in Table S1.
BODIPY—palmitate uptake assay
In vivo hepatic uptake of lipid was measured by fasting
Exoc5-SMKO and littermate controls overnight. A single
IP injection of 50 μg BODIPY-conjugated palmitate diluted
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in 1% BSA was administered. Mice were sacrificed by
isoflurane overdose 1 h after injection and tissues were
harvested immediately. Livers were mechanically homoge-
nized following the addition of 2 ml of radio-
immunoprecipitation assay buffer. Lysates were centrifuged
at 1000g and the fluorescence of the supernatant was
measured ex/em 488/512. The fluorescence values were
normalized by protein concentration determined by
bicinchoninic acid assay.
Statistical methods
Graphs show mean ± standard deviation, unless otherwise
indicated. Statistical comparisons between the subgroups were
assessed by one-way analysis of variance (ANOVA). In all
other cases, a Student’s t-test was performed to calculate p
values and determine if there was a significant difference be-
tween two groups. p values of less than 0.05 were considered
statistically significant. Area under the curve (positive incre-
mental) values were calculated based on the trapezoid model,
relative to the baseline, using the GraphPad Prism software
(GraphPad, Inc) (40).
Data availability
All relevant data generated during this study are included in
this published article (and its supplementary information files).
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